戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ds approved this study, and all participants gave informed consent.
2 titutional review board and all participants gave informed consent.
3 itutional review board, and all participants gave informed consent.
4 ard approved the study, and all participants gave informed consent.
5 onal review board approval, and all patients gave informed consent.
6 standardized questionnaire, and all patients gave informed consent.
7 institutional review board, and all patients gave informed consent.
8                                 All subjects gave informed consent.
9                                 Participants gave informed consent.
10 itutional ethics committee, and all patients gave informed consent.
11                                      Readers gave informed consent.
12 ter number, PR(HG)36/2000), and all patients gave informed consent.
13 Institutional Review Board, and all subjects gave informed consent.
14                      All participating women gave informed consent.
15 oard approval was obtained, and participants gave informed consent.
16 PAA-compliant protocol, and all participants gave informed consent.
17               The participating radiologists gave informed consent.
18 itutional review board, and all participants gave informed consent.
19 d and was compliant with HIPAA; each patient gave informed consent.
20 oved by a human research committee; patients gave informed consent.
21                                     Patients gave informed consent.
22 in two groups, recent MI and chronic MI, and gave informed consent.
23 sented for primary care on selected days and gave informed consent.
24                                 Each subject gave informed consent.
25  William Beaumont Hospital, and all patients gave informed consent.
26 nteer and in a patient with MS, both of whom gave informed consent.
27 patient, or members of the patient's family, gave informed consent.
28  for scanning the 10 volunteers, all of whom gave informed consent.
29 tutional review board approval, and patients gave informed consent.
30 and the subjects and/or a parent or guardian gave informed consent.
31  regional ethics committee, and all patients gave informed consent.
32 nstitutional review board-approved study and gave informed consent.
33 etween March 2015 through November 2019; 440 gave informed consent.
34  approval was obtained, and all participants gave informed consent.
35              Participants and research sites gave informed consent.
36                                 All patients gave informed consent.
37 tutional review boards, and all participants gave informed consent.
38 of miscarriage, and were willing and able to give informed consent.
39 isease, before subjects lose the capacity to give informed consent.
40 ver were invited to participate and asked to give informed consent.
41 rials or clinical practice, and were able to give informed consent.
42 tive study site clinics and who were able to give informed consent.
43 te asthma exacerbations were recruited after giving informed consent.
44 is of inclusion and exclusion criteria after giving informed consent.
45 utional review board-approved study, and all gave informed consent; 20 volunteers were healthy subjec
46                                 All patients gave informed consent according to an institutionally ap
47          Participating patients and families gave informed consent and chose between nonoperative man
48 hich included randomly assigned patients who gave informed consent and excluded those without 6-month
49                Of 986 eligible patients, 674 gave informed consent and returned a complete questionna
50          All subjects participating in DMIST gave informed consent and the study was HIPAA-compliant.
51 5.6 [standard deviation]; range, 8-66 years) gave informed consent and underwent MR spectroscopy and
52 s in Epidemiology guidelines, adult subjects gave informed consent and were identified via Diagnostic
53                                 Participants gave informed consent and were instructed on use of oral
54 an age, 57.1 years; range, 50-69 years), who gave informed consent and who had suspicious screening m
55  women of reproductive age (15-45 years) who gave informed consent and who planned to remain in the a
56  53 consecutive patients were enrolled after giving informed consent and fulfilling study entry crite
57                    Parent(s) of all subjects gave informed consent (and children gave assent) for par
58 le if they were older than 18 years, able to give informed consent, and had circular or oval postoper
59 ecruited through YouGov in February 2023 and gave informed consent (Cambridge University Ethics HSSRE
60 nrolment if they were unwilling or unable to give informed consent, did not understand the study purp
61                                     Patients gave informed consent for all procedures.
62                                5125 patients gave informed consent for genotyping.
63  Five of these patients were contactable and gave informed consent for inclusion in the study.
64 controls from three beryllium industries who gave informed consent for participation.
65  All subjects or their legal representatives gave informed consent for participation.
66 y assessment, 142 of 162 patients approached gave informed consent for participation.
67                                  All parents gave informed consent for patient sedation.
68                                 All patients gave informed consent for this institutional review boar
69  weight, 78.9 kg +/- 18.3; 12 men, 10 women) gave informed consent for this prospective institutional
70                                     Patients gave informed consent for use of medical records.
71 tive review from patients who had previously given informed consent for prospective studies.
72 nt whole-brain (18)F-fluorocholine PET after giving informed consent in this institutional review boa
73 at all donors of biological materials should give informed consent, including oocyte and sperm donors
74                                        After giving informed consent, patients with symptomatic leiom
75                                 All subjects gave informed consent to participate and were examined u
76 ho were part of the follow-on clinical trial gave informed consent to participate in a longitudinal n
77                         Parents and children gave informed consent to participate in the research.
78                            Of the 80,759 who gave informed consent to participate, 75,422 (93%) were
79      Institutional review board approval was given; informed consent was waived.
80 re defined and eligible individuals, who had given informed consent, were vaccinated and followed up